The Venture Codex Logo

The Venture Codex

Fosun Pharma

No. 1289 Yishan Road, Shanghai, 200233, China

Overview

Biopharmaceutical and healthcare company with global operations.

Founded

1994

Deals ยท 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series B
Series C

Geographic focus

China
United Kingdom
United States

Sector focus

Biotechnology
Health Care
Medical
Pharmaceutical

Investment portfolio

9rounds
NAMEDATESIZE
Conjustar
Jan 2024Led
$13 MSeries A
Gyroscope Therapeutics
Mar 2021Participated
$148 MSeries C
Jianjia Robot
Sep 2020Participated
$15 MSeries B
Butterfly Network
Sep 2018Participated
$250 MSeries D
TytoCare
Jan 2018Participated
$25 MOther Equity
Ambrx
Aug 2016Participated
$45 MOther Equity
Spirosure
Jun 2016Led
$17 MSeries C
TytoCare
Jul 2015Participated
$11 MSeries B
Saladax Biomedical
Mar 2013Led
$22 MOther Equity
Conjustar
Jan 2024Led
$13 MSeries A
Gyroscope Therapeutics
Mar 2021Participated
$148 MSeries C
Jianjia Robot
Sep 2020Participated
$15 MSeries B
Butterfly Network
Sep 2018Participated
$250 MSeries D
TytoCare
Jan 2018Participated
$25 MOther Equity
Ambrx
Aug 2016Participated
$45 MOther Equity
Spirosure
Jun 2016Led
$17 MSeries C
TytoCare
Jul 2015Participated
$11 MSeries B
Saladax Biomedical
Mar 2013Led
$22 MOther Equity
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Fosun Pharma: 9 funding rounds are recorded in the selected participation categories.All available history.
Fosun Pharma: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A10
Series B02
Series C+12
Other Equity12

Monthly Deal Activity

Fosun Pharma: 9 deals are recorded across 164 months.All available history.
Fosun Pharma: 9 deals are recorded across 164 months. All available history
MonthDeals
Mar '131
Apr '130
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '140
Oct '140
Nov '140
Dec '140
Jan '150
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '151
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '161
Jul '160
Aug '161
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '181
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '181
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '201
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '211
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '241
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Fosun Pharma: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Fosun Pharma: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
Hardware & Robotics2

Deal Size Distribution

Fosun Pharma: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Fosun Pharma: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M5
$25M-$50M2
$50M-$100M0
$100M-$250M1
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Fosun Pharma: United States has the largest recorded deal count among the displayed regions (6 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Fosun Pharma: United States has the largest recorded deal count among the displayed regions (6 deals). All available history
RegionDeals
United States6
China2
Europe1
Fosun Pharma: 20 co-investors are shown, with Cambia Health Solutions sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Fosun Pharma: 20 co-investors are shown, with Cambia Health Solutions sharing 2 recorded deals. All available history
Co-investorShared deals
Cambia Health Solutions2
LionBird2
OrbiMed2
Walgreens2
Apricot Capital1
Baidu Ventures1
Bill & Melinda Gates Foundation1
Cambridge Innovation Capital1
Carmen Innovation1
China Everbright1
Fidelity Management & Research Company1
Forbion1
Hillhouse Capital1
HOPU Investments1
Iconical1
Niterra1
Northeast Securities1
Ohio Innovation Fund1
Ping An1
Qure1

Investment Strategy

Fosun Pharma: Led accounts for 33% and participating for 67% of round participation.All available history.
Fosun Pharma: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led333%
Participating667%
Fosun Pharma: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Fosun Pharma: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead3100%
Co-led00%

Team

Guo Guangchang

Founder

Hongfei Jia

SVP, Joint Chief Investment Officer and General Manager of International Operations Department

Liang Xinjun

Founder

Qian Ren

Chief Supervisor

Wang Donghua

Vice President and General Manager of Public Affairs Department

Wang Yao

Vice President and General Manager of Medical Devices Division

Wen Deyong

Vice President and Executive Deputy Director of Pharmaceutical Industry Management Committee

Xiaohui Guan

Senior Vice President and Chief Financial Officer

Zhou Biao

SVP, General Manager of Legal Department and General Manager of Independent Inspectors Department